Recombinant Human GPBAR1 Protein，His

GPBAR1, also known as the G-protein-coupled bile acid receptor 1, has garnered significant attention in recent years due to its crucial role in regulating bile acid homeostasis, metabolism, and inflammatory responses. As a member of the G-protein-coupled receptor (GPCR) family, GPBAR1 is primarily expressed in the enteroendocrine cells of the intestine and in various organs, including the liver and adipose tissue. Its activation by bile acids triggers several signaling pathways, influencing metabolic processes and potentially offering therapeutic avenues for conditions such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease. The research on GPBAR1 recombinant protein has focused on elucidating its structure-function relationship, mechanisms of action, and potential as a drug target. Advances in recombinant protein technology have enabled the production and functional characterization of GPBAR1, facilitating the exploration of its therapeutic potential. Studies have shown that GPBAR1 activation can enhance insulin sensitivity, promote energy expenditure, and exert anti-inflammatory effects, making it a compelling candidate for drug development. Furthermore, understanding the intricate signaling pathways associated with GPBAR1 could provide insights into broader metabolic regulatory networks and their implications in metabolic syndromes. As research continues to unfold, GPBAR1 represents a promising avenue for developing innovative treatments that address metabolic disorders and improve overall health outcomes.